| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2008;118:26-32.)
© 2008 American Heart Association, Inc.
Congenital Heart Disease |
From the Department of Cardiology, Academic Medical Center, Amsterdam (C.L.V., B.J.B., B.J.M.M.); Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht (C.L.V., C.S.P.M.U., D.E.G.); Department of Cardiology, Leiden University Medical Center, Leiden (E.T.v.d.V., H.W.V.); Department of Cardiology, Radboud University Medical Center, Nijmegen (F.J.M., A.P.J.v.D.); Department of Cardiology, University Medical Center Groningen, Groningen (P.G.P.); and Department of Cardiology, University Medical Center Utrecht, Utrecht (B.J.M.M.), Netherlands.
Correspondence to Barbara J.M. Mulder, MD, PhD, FESC, Department of Cardiology, Room B2-240, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, Netherlands. E-mail b.j.mulder{at}amc.uva.nl
Received December 3, 2007; accepted April 11, 2008.
Background— Gender differences in prognosis have frequently been reported in cardiovascular disease but less so in congenital heart disease. We investigated whether gender is associated with outcome in adult patients with congenital heart disease.
Methods and Results— From the CONgenital CORvitia (CONCOR) national registry for adults with congenital heart disease, 7414 patients were identified. All outcomes before entry into the registry and during subsequent follow-up were recorded, and differences between men and women were analyzed with the underlying congenital heart defect taken into account. Median age at the end of follow-up was 35 years (range, 17 to 91 years); 49.8% were female. No gender difference in mortality was found. Women had a 33% higher risk of pulmonary hypertension (odds ratio [OR]=1.33; 95% CI, 1.07 to 1.65; P=0.01), a 33% lower risk of aortic outcomes (OR=0.67; 95% CI, 0.50 to 0.90; P=0.007), a 47% lower risk of endocarditis (OR=0.53; 95% CI, 0.40 to 0.70; P<0.001), and a 55% lower risk of an implantable cardioverter-defibrillator (OR=0.45; 95% CI, 0.26 to 0.80; P=0.006). Furthermore, the risk of arrhythmias appeared to be lower in women (OR=0.88; 95% CI, 0.77 to 1.02; P=0.08).
Conclusions— The risk of several major cardiac outcomes in adult patients with congenital heart disease appears to vary by gender.
This article has been cited by other articles:
![]() |
G. Yong, P. Khairy, P. De Guise, A. Dore, F. Marcotte, L.-A. Mercier, S. Noble, and R. Ibrahim Pulmonary Arterial Hypertension in Patients With Transcatheter Closure of Secundum Atrial Septal Defects: A Longitudinal Study Circ Cardiovasc Interv, October 1, 2009; 2(5): 455 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Warnes Sex Differences in Congenital Heart Disease: Should a Woman Be More Like a Man? Circulation, July 1, 2008; 118(1): 3 - 5. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |